Evidence map›Paper›PMID 36899865›Full record

ArticleCells2023

Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut.

Michele d'Angelo, Laura Brandolini, Mariano Catanesi, Vanessa Castelli, Cristina Giorgio, Margherita Alfonsetti, Mara Tomassetti, Mara Zippoli, Elisabetta Benedetti, Maria Candida Cesta and 4 more

Open access · goldFull text read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Michele d'AngeloDept. of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-3693-840X
Laura BrandoliniDompé Farmaceutici S.p.A., via Campo di Pile snc, 67100 L'Aquila, Italy.ORCID 0000-0002-5959-4443
Mariano CatanesiDept. of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Vanessa CastelliDept. of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-7005-3218
Cristina GiorgioDompé Farmaceutici S.p.A., via De Amicis 95, 80131 Napoli, Italy.
Margherita AlfonsettiDept. of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-0261-3148
Mara TomassettiDompé Farmaceutici S.p.A., via De Amicis 95, 80131 Napoli, Italy.
Mara ZippoliDompé Farmaceutici S.p.A., via De Amicis 95, 80131 Napoli, Italy.ORCID 0000-0003-3749-1176
Elisabetta BenedettiDept. of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-6740-7724
Maria Candida CestaDompé Farmaceutici S.p.A., via Campo di Pile snc, 67100 L'Aquila, Italy.ORCID 0000-0002-4847-2985
Sandro ColagioiaDompé Farmaceutici S.p.A., via Campo di Pile snc, 67100 L'Aquila, Italy.
Pasquale CocchiaroDompé Farmaceutici S.p.A., via De Amicis 95, 80131 Napoli, Italy.ORCID 0000-0002-6436-2399
Annamaria CiminiDept. of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-2737-7970
Marcello AllegrettiDompé Farmaceutici S.p.A., via Campo di Pile snc, 67100 L'Aquila, Italy.ORCID 0000-0002-0617-0233
University of L'Aquila · ITDompé (Italy) · ITIBSA Farmaceutici (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal barrier is the main contributor to gut homeostasis. Perturbations of the intestinal epithelium or supporting factors can lead to the development of intestinal hyperpermeability, termed "leaky gut". A leaky gut is characterized by loss of epithelial integrity and reduced function of the gut barrier, and is associated with prolonged use of Non-Steroidal Anti-Inflammatories. The harmful effect of NSAIDs on intestinal and gastric epithelial integrity is considered an adverse effect that is common to all drugs belonging to this class, and it is strictly dependent on NSAID properties to inhibit cyclo-oxygenase enzymes. However, different factors may affect the specific tolerability profile of different members of the same class. The present study aims to compare the effects of distinct classes of NSAIDs, such as ketoprofen (K), Ibuprofen (IBU), and their corresponding lysine (Lys) and, only for ibuprofen, arginine (Arg) salts, using an in vitro model of leaky gut. The results obtained showed inflammatory-induced oxidative stress responses, and related overloads of the ubiquitin-proteasome system (UPS) accompanied by protein oxidation and morphological changes to the intestinal barrier, many of these effects being counteracted by ketoprofen and ketoprofen lysin salt. In addition, this study reports for the first time a specific effect of R-Ketoprofen on the NFkB pathway that sheds new light on previously reported COX-independent effects, and that may account for the observed unexpected protective effect of K on stress-induced damage on the IEB.

Indexed as

KetoprofenAnti-Inflammatory Agents, Non-SteroidalHumansIbuprofenOxidative StressAnti-Inflammatory Agents, Non-SteroidalIbuprofenKetoprofenanti-inflammatoryinflammationmacrophagesoxidative stresstight junctiontransepithelial electrical resistance

Identifiers

PMID36899865
PMCPMC10001324
OpenAlexW4322501126

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read79
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.